Sign in

CIK 0000072444 · Accelerated filer<br>Smaller reporting company

Vaxart, Inc.

Sign in to watch
Ticker
VXRT
Exchange
OTC
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
591212264
Phone
(650) 550-3500
Business address
310 UTAH AVENUE, SUITE 150, SOUTH SAN FRANCISCO, CA
Former names
Aviragen Therapeutics, Inc., Biota Pharmaceuticals, Inc., NABI BIOPHARMACEUTICALS, NABI BIOPHARMACEUTICALS, NABI /DE/, NORTH AMERICAN BIOLOGICALS INC
  1. DEFA14A Proxy Proxy Materials
  2. DEFA14A Proxy Proxy Materials
  3. DEFA14A Proxy Proxy Materials
  4. 8-K Event Regulation FD disclosure
  5. SC 13G Stake Amended Statement of Ownership
  6. DEFA14A Proxy Proxy Materials
  7. SC 13D Stake Beneficial Ownership Report
  8. DEFA14A Proxy Proxy Materials
  9. DEFA14A Proxy Proxy Materials
  10. DEFA14A Proxy Proxy Materials
  11. 8-K Event Other events
  12. DFAN14A Other Proxy Soliciting Materials
  13. DEFA14A Proxy Proxy Materials
  14. 8-K Event Material agreement
  15. DFAN14A Other Proxy Soliciting Materials
  16. CORRESP Other Correspondence Between Filers and SEC Staff
  17. DEFA14A Proxy Proxy Materials
  18. DEFA14A Proxy Proxy Materials
  19. DFAN14A Other Proxy Soliciting Materials
  20. UPLOAD Other SEC-generated Letter

Page 46 of 89 · 1,773 filings